1 Day
Source:
الحقيقة الدولية
FDA cautions on unlicensed peptides
The General Food and Drug Authority has warned against the trading and use of unlicensed peptide substances, such as BPC-157, TB-500, GHK-Cu, Kisspeptin, IGF-1, Tesamorelin, and Retatrutide, which are promoted by some social media platforms and fitness centers in violation of regulations. These substances pose serious health risks, including hormonal imbalances and organ dysfunction. The authority confirmed that most of these products are not registered in the kingdom, are of unknown origin and ingredients, and have potential negative effects on the heart, liver, and reproductive system. Notably, Retatrutide is still under research and has not been officially marketed. The authority continues its regulatory campaigns, which have resulted in the closure of more than 10 social media pages and 6 fitness centers. It emphasizes the importance of verifying the authorization of any substance through its platforms to ensure safety, and provides channels for complaints and inquiries.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)